News &amp; Updates

By itself, chronic hepatitis B infection compromises bone health by increasing bone resorption, regardless of the use of antiretroviral drugs, a recent study has found.

Chronic hepatitis B impairs bone health regardless of medication

Antibiotic regimens proven safe in premature infants with intra-abdominal infections

24 May 2021 by

Three antibiotic regimens have been found safe and tolerable in critically ill premature infants with complicated intra-abdominal infections (CIAIs), a study has shown. No differences are seen in mortality, adverse events (AEs), or serious AEs between any of the commonly used antimicrobial regimens.

Antibiotic regimens proven safe in premature infants with intra-abdominal infections

Smartphone app helps healthcare workers deal with COVID-19’s mental toll

24 May 2021 by

Mindfulness-based mobile health (mHealth) interventions could help ease the psychological burden of caring for patients with the novel coronavirus disease (COVID-19) among healthcare workers when used in conjunction with proven therapies, according to a recent study.

Smartphone app helps healthcare workers deal with COVID-19’s mental toll

What factors predict staphylococcal bacteraemia in paediatric patients?

The epidemiology of organisms associated with bacteraemia is similar between paediatric or adolescent patients and adults, but the risk factors differed from that seen in the population, reports a study.

What factors predict staphylococcal bacteraemia in paediatric patients?

Positive youth development softens blow of COVID-19 on mental health

Positive youth development (PYD) could protect against symptoms of post-traumatic stress disorder (PTSD) brought about by the novel coronavirus disease (COVID-19) pandemic, a recent study has found.

Positive youth development softens blow of COVID-19 on mental health

Ibrexafungerp shows promise as first non-azole treatment for vulvovaginal candidiasis

The novel oral triterpenoid antifungal ibrexafungerp demonstrated superiority over placebo in reducing signs and symptoms of vulvovaginal candidiasis, according to results of the phase III VANISH-306 trial presented at ACOG 2021.

Ibrexafungerp shows promise as first non-azole treatment for vulvovaginal candidiasis

Antibody response to COVID-19 foreshadows outcomes

The presence of neutralizing antibodies targeting the SARS-CoV-2 protein seems to predict the outcomes of the novel coronavirus disease (COVID-19), a recent study has found.

Antibody response to COVID-19 foreshadows outcomes

Stroke rate lower than thought in critically ill COVID-19 patients

Stroke occurred at a relatively low rate of 2.2 percent in critically ill COVID-19 patients in the intensive care unit (ICU) — which is lower than previously thought among COVID-19 patients, according to data from the COVID-19 Critical Care Consortium (CCCC) registry presented at the AAN 2021 Meeting.

Stroke rate lower than thought in critically ill COVID-19 patients

Telerehab helps severe COVID-19 survivors get back on their feet

Survivors of severe COVID-19 face another challenge following their discharge from the hospital: a harder recovery and low functional exercise capacity. But the good news is that a simple telerehabilitation programme may help them return to form after 3 months, as reported in a study.

Telerehab helps severe COVID-19 survivors get back on their feet

To combat COVID-19, focus on social behaviour instead of case counts, says study

Despite lockdowns and restrictions, night-time populations start to swell following reports of declining cases of the novel coronavirus disease (COVID-19), hinting at easing caution on a personal level, according to a Japan study. Such changes in behaviour may in turn lead to an uptick in infections.

To combat COVID-19, focus on social behaviour instead of case counts, says study